ANIP FY 2016 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$129M+68.5% YoY

Gross Profit

$80M62.1% margin

Operating Income

$20M15.6% margin

Net Income

$4M3.1% margin

EPS (Diluted)

$0.34

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

-$122M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$323M

Total Liabilities

$153M

Stockholders' Equity

$170M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$129M	$76M	+68.5%
Gross Profit	$80M	$64M	+25.5%
Operating Income	$20M	$33M	-38.6%
Net Income	$4M	$15M	-74.4%